Regional differences in treatment response and three year course of schizophrenia across the world

Journal of Psychiatric Research

Volumn 46, Issue 7, 2012, Pages 856-864

  Novick, Diego ^a,b   Haro, Josep Maria ^c   Hong, Jihyung ^a,d   Brugnoli, Roberto ^e   Lepine, Jean Pierre ^f   Bertsch, Jordan ^c   Karagianis, Jamie ^a   Dossenbach, Martin ^g   Alvarez, Enric ^b  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^e Fondazione italiana per lo studio della Schizophrenia   (Italy)

^f HÔPITAL FERNAND WIDAL   (France)

^g Eli Lilly GesmbH   (Austria)

Author keywords

Course; Observational; Region; Response; Schizophrenia; World

Indexed keywords

ADULT; AFRICA; ARTICLE; ASIA; DISEASE COURSE; EUROPE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SCHIZOPHRENIA; SOCIAL STATUS; SOUTH AND CENTRAL AMERICA; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84862020687     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.03.017     Document Type: Article

References (40)

1. Amore M., Menchetti M., Tonti C., Scarlatti F., Lundgren E., Esposito W., et al. Predictors of violent behavior among acute psychiatric patients: clinical study. Psychiatry and Clinical Neurosciences 2008, 62:247-255.
2. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 2005, 162:441-449.
3. Angermeyer M.C., Kuhn L., Goldstein J.M. Gender and the course of schizophrenia: differences in treated outcomes. Schizophrenia Bulletin 1990, 16:293-307.
4. APA Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association (APA), Washington, DC. 4th ed.
5. Birchwood M., Cochrane R., Macmillan F., Copestake S., Kucharska J., Carriss M. The influence of ethnicity and family structure on relapse in first-episode schizophrenia. A comparison of Asian, Afro-Caribbean, and white patients. British Journal of Psychiatry 1992, 161:783-790.
6. Ciudad A., álvarez E., Bobesc J., San L., Polavieja P., Gilaberte I. Remission in schizophrenia: results from a 1-year follow-up observational study. Schizophrenia Research 2009, 108:214-222.
7. Cohen A., Patel V., Thara R., Gureje O. Questioning an axiom: better prognosis for schizophrenia in the developing world?. Schizophrenia Bulletin 2008, 34:229-244.
8. Doering S., Muller E., Kopcke W., Pietzcker A., Gaebel W., Linden M., et al. Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophrenia Bulletin 1998, 24:87-98.
9. Dossenbach M., Arango-Davila C., Silva Ibarra H., Landa E., Aguilar J., Caro O., et al. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Journal of Clinical Psychiatry 2005, 66:1021-1030.
10. Eaton W.W., Bilker W., Haro J.M., Herrman H., Mortensen P.B., Freeman H., et al. Long-term course of hospitalization for schizophrenia: part II. Change with passage of time. Schizophrenia Bulletin 1992, 18:229-241.
11. Emsley R., Rabinowitz J., Medori R. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophrenia Research 2007, 89:129-139.
12. Gaebel W., Pietzcker A. Prospective study of course of illness in schizophrenia: part II. Prediction of outcome. Schizophrenia Bulletin 1987, 13:299-306.
13. Grossman L.S., Harrow M., Rosen C., Faull R. Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatric Services 2006, 57:844-850.
14. Haro J.M., Edgell E.T., Jones P.B., Alonso J., Gavart S., Gregor K.J., et al. The European schizophrenia outpatient health outcomes (SOHO) study: rationale, methods and recruitment. Acta Psychiatrica Scandinavica 2003, 107:222-232.
15. Haro J.M., Kamath S.A., Ochoa S., Novick D., Rele K., Fargas A., et al. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatrica Scandinavica 2003, 107(Suppl. 416):16-23.
16. Haro J.M., Edgell E.T., Novick D., Alonso J., Kennedy L., Jones P.B., et al. Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatrica Scandinavica 2005, 111:220-231.
17. Haro J.M., Novick D., Suarez D., Alonso J., Lepine J.P., Ratcliffe M. Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study. Journal of Clinical Psychopharmacology 2006, 26:571-578.
18. Haro J.M., Ochoa S., Gervin M., Mavreas V., Jones P. Assessment of remission in schizophrenia with the CGI and CGI-SCH scales. [Letter]. Acta Psychiatrica Scandinavica 2007, 115:163-164.
19. Harrison G., Hopper K., Craig T., Laska E., Siegel C., Wanderling J., et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. British Journal of Psychiatry 2001, 178:506-517.
20. Huber G. The heterogeneous course of schizophrenia. Schizophrenia Research 1997, 28:177-185.
21. Jablensky A., Sartorius N., Ernberg G., Anker M., Korten A., Cooper J.E., et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine Monograph Supplement 1992, 20:1-97.
22. Karagianis J., Novick D., Pecenak J., Haro J.M., Dossenbach M., Treuer T., et al. Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients. International Journal of Clinical Practice 2009, 63:1578-1588.
23. Kebede D., Alem A., Shibre T., Negash A., Fekadu A., Fekadu D., et al. Onset and clinical course of schizophrenia in Butajira-Ethiopia-a community-based study. Social Psychiatry and Psychiatric Epidemiology 2003, 38:625-631.
24. Kulhara P., Chakrabarti S. Culture and schizophrenia and other psychotic disorders. Psychiatric Clinics of North America 2001, 24:449-464.
25. Kurihara T., Kato M., Reverger R., Yagi G. Clinical outcome of patients with schizophrenia without maintenance treatment in a nonindustrialized society. Schizophrenia Bulletin 2002, 28:515-524.
26. Leff J., Wig N.N., Bedi H., Menon D.K., Kuipers L., Korten A., et al. Relatives' expressed emotion and the course of schizophrenia in Chandigarh. A two-year follow-up of a first-contact sample. British Journal of Psychiatry 1990, 156:351-356.
27. Macmillan J.F., Gold A., Crow T.J., Johnson A.L., Johnstone E.C. The Northwick Park study of first episodes of schizophrenia. IV. Expressed emotion and relapse. British Journal of Psychiatry 1986, 148.
28. Murphy H.B., Raman A.C. The chronicity of schizophrenia in indigenous tropical peoples. Results of a twelve-year follow-up survey in Mauritius. British Journal of Psychiatry 1971, 118:489-497.
29. Palao D.J., Arauxo A., Brunet M., Marquez M., Bernardo M., Ferrer J., et al. Positive versus negative symptoms in schizophrenia: response to haloperidol. Progress in Neuro-psychopharmacology & Biological Psychiatry 1994, 18:155-164.
30. Patel V., Cohen A., Thara R., Gureje O. Is the outcome of schizophrenia really better in developing countries?. Revista Brasileira de Psiquiatria 2006, 28:149-152.
31. Perkins D., Lieberman J., Gu H., Tohen M., McEvoy J., Green A., et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. British Journal of Psychiatry 2004, 185:18-24.
32. Ran M., Xiang M., Huang M., Shan Y. Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community. British Journal of Psychiatry 2001, 178:154-158.
33. Robinson D.G., Woerner M.G., McMeniman M., Mendelowitz A., Bilder R.M. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry 2004, 161:473-479.
34. Röpcke B., Eggers C. Early-onset schizophrenia: a 15-year follow-up. European Child & Adolescent Psychiatry 2005, 14:341-350.
35. San L., Ciudad A., Alvarez E., Bobes J., Gilaberte I. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. European Psychiatry 2007, 22:490-498.
36. Simonsen E., Friis S., Haahr U., Johannessen J.O., Larsen T.K., Melle I., et al. Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors. Acta Psychiatrica Scandinavica 2007, 116:54-61.
37. Thara R. Twenty-year course of schizophrenia: the Madras Longitudinal Study. Canadian Journal of Psychiatry 2004, 49:564-569.
38. Usall J., Ochoa S., Araya S., Marquez M. Gender differences and outcome in schizophrenia: a 2-year follow-up study in a large community sample. European Psychiatry 2003, 18:282-284.
39. WHO Schizophrenia: an international follow-up study 1979, John Wiley and Sons, Chichester, UK.
40. WHO The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines 1992, World Health Organisation (WHO), Geneva, Switzerland.